Menu
Search
|

Menu

Close
X

Merck & Co Inc MRK.N (New York Stock Exchange)

80.77 USD
+0.94 (+1.18%)
As of Feb 22
chart
Previous Close 79.83
Open 79.98
Volume 2,431,289
3m Avg Volume 4,297,159
Today’s High 80.86
Today’s Low 79.92
52 Week High 80.86
52 Week Low 52.83
Shares Outstanding (mil) 2,600.38
Market Capitalization (mil) 210,032.41
Forward P/E 34.72
Dividend (Yield %) 0.55 ( 3.14 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.69 Mean rating from 16 analysts

KEY STATS

Revenue (mm, USD)
FY18
42,294
FY17
40,122
FY16
39,807
EPS (USD)
FY18
2.327
FY17
1.820
FY16
1.403
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
34.72
35.75
Price to Sales (TTM)
vs sector
4.97
9.77
Price to Book (MRQ)
vs sector
--
4.49
Price to Cash Flow (TTM)
vs sector
26.79
26.04
Total Debt to Equity (MRQ)
vs sector
--
16.68
LT Debt to Equity (MRQ)
vs sector
--
13.13
Return on Investment (TTM)
vs sector
--
12.61
Return on Equity (TTM)
vs sector
--
13.81

EXECUTIVE LEADERSHIP

Kenneth Frazier
Chairman of the Board, President, Chief Executive Officer, Since 2011
Salary: $1,572,210.00
Bonus: $2,686,580.00
Robert Davis
Chief Financial Officer, Executive Vice President, Since 2014
Salary: $1,018,270.00
Bonus: $1,216,160.00
Steven Mizell
Chief Human Resource Officer, Since 2018
Salary: --
Bonus: --
Sanat Chattopadhyay
Executive Vice President and President - Merck Manufacturing Division, Since 2016
Salary: --
Bonus: --
Richard DeLuca
Executive Vice President, President - Merck Animal Health, Since 2011
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

2000 Galloping Hill Rd
KENILWORTH   NJ   07033-1310

Phone: +1908.7404000

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.

SPONSORED STORIES